LGALS3 and metabolic syndrome: Loss of Lgals3 function was associated with accelerated development of obesity, increased adiposity, insulin resistance, metabolic syndrome, and type II diabetes in mice receiving a high fat diet ([51, 52]; however, data from [53, 54] suggest low Lgals3 expression as potentially protective against type II DM).